Please use this identifier to cite or link to this item:
Title: Relationship between neutrophil-to-limphocyte ratio and erithropoietin resistance index. A multicenter study
Authors: Valga, Francisco
Monzon, Tania
Henriquez, Fernando
Santana-del-Pino, Angelo 
Anton, Gloria
UNESCO Clasification: 320506 Nefrología
120903 Análisis de datos
240401 Bioestadística
Issue Date: 2018
Journal: Nephrology Dialysis Transplantation 
Conference: 55th Congress of the European-Renal-Association (ERA) and European-Dialysis-and-Transplantation-Association (EDTA) 
Abstract: INTRODUCTION AND AIMS: Neutrophil-to-lymphocyte ratio (NLI) is an emerging inflammation biomarker. Inflammation has an important influence in the erythropoietin resistance. So, there could be a relationship between NLI and erythropoietin resistance. METHODS: We study hemodialysis sessions of 534 patients in our 4 hemodialysis centers during June 2017. A total of 137 patients was excluded to our study due to different causes. Finally, we study 397 patients. NLI was calculated by the quotient between absolute value of neutrophils and absolute value of lymphocytes in the hemogram. The erythropoietin hyporresponsiveness index (EHRI) was obtained calculating the weekly dose of erythropoietin divided by the dry weight and divided again by the levels of serum hemoglobin. RESULTS: EHRI was divide into quartiles and compared with the NLI averages in the four groups, there was statistically significant differences (p=0.00058) (Figure 1). In the regression analyzes, the NLI value was able to predict the EHRI (p>0.0001) (R2 0.045) (Figure 2). CONCLUSIONS: NLI could be considered an acceptable biomarker of erythropoietin resistance.
ISSN: 0931-0509
DOI: 10.1093/ndt/gfy104.SP350
Source: Nephrology Dialysis Transplantation [ISSN 0931-0509], v. 33 (S1), p. i463
Appears in Collections:Actas de congresos
Adobe PDF (323,09 kB)
Show full item record

Google ScholarTM




Export metadata

Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.